EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Advances in Bioengineering for Treatment of Metabolic Disorders

Dr. Emily Harris, Dr. Oliver Smith

American Journal of Biomedical Engineering · 2022-04-30 · 3 (2) · 11-16

DOI: 10.71465/ajbe448 ↗

At a glance

Journal article in American Journal of Biomedical Engineering, published online on 2022-04-30. Written by Dr. Emily Harris and 1 co-authors. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metabolic disorders, including diabetes, obesity, and dyslipidemia, represent a significant global health challenge. Recent advancements in bioengineering have opened new avenues for the treatment and management of these disorders, offering innovative solutions that go beyond conventional pharmaceutical approaches. This article reviews the role of bioengineering in the development of novel therapeutic strategies for metabolic disorders, focusing on areas such as gene therapy, tissue engineering, biosensors, and personalized medicine. It also highlights the potential of bioengineering technologies in addressing the root causes of metabolic diseases, promoting long-term health, and improving quality of life.

Cite

APA

Harris, D. E., & Smith, D. O. (2022). Advances in Bioengineering for Treatment of Metabolic Disorders. American Journal of Biomedical Engineering, 3(2), 11-16. https://doi.org/10.71465/ajbe448

Vancouver

Harris DE, Smith DO. Advances in Bioengineering for Treatment of Metabolic Disorders. American Journal of Biomedical Engineering. 2022;3(2):11-16. doi:10.71465/ajbe448

BibTeX
@article{Harris2022,
  author = {Harris, Dr. Emily and Smith, Dr. Oliver},
  title = {Advances in Bioengineering for Treatment of Metabolic Disorders},
  journal = {American Journal of Biomedical Engineering},
  year = {2022},
  volume = {3},
  number = {2},
  pages = {11--16},
  doi = {10.71465/ajbe448}
}
Start for free →